Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.8M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
+17.3M
-
Total reported value, excl. options
-
$311M
-
Value change
-
+$311M
-
Number of buys
-
32
-
Price
-
$17.98
Significant Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q3 2021
32 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
of 67.8M outstanding shares and own 25.5% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (13.2M shares), SAMLYN CAPITAL, LLC (1.68M shares), Woodline Partners LP (387K shares), BlackRock Inc. (332K shares), Monashee Investment Management LLC (305K shares), Tudor Investment Corp Et Al (287K shares), JPMORGAN CHASE & CO (203K shares), VANGUARD GROUP INC (200K shares), GOLDMAN SACHS GROUP INC (166K shares), and Hudson Bay Capital Management LP (100K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.